Human Trials Of COVID-19 Vaccine In Odisha Capital From Tomorrow:                     "Covid-19 vaccine"       Bhubaneswar: Human ...

Human Trials Of COVID-19 Vaccine In Odisha Capital From Tomorrow: 

     

             "Covid-19 vaccine"      

Bhubaneswar: Human clinical trials of the country’s indigenously developed COVID-19 vaccine is set to begin this week at a Bhubaneswar-based institute — one of the 12 centres selected by the ICMR for conducting phase one and two of the process, a senior official said.

The human trials of BBV152 COVID Vaccine or Covaxin will begin on Wednesday in a special laboratory set up at the Institute of Medical Sciences and SUM (IMS & SUM) Hospital, in accordance with the protocols laid down by the Drugs Controller General of India (DCGI), the official at the facility here said.The special laboratory — Preventive and Therapeutic Clinical Trial Unit (PTCTU) — was inaugurated at the institute on Monday by its dean Gangadhar Sahoo.

          Describing the new PTCTU as the first such “dedicated human trial unit” in Odisha, Rao said it would facilitate clinical research in future. Some people have already volunteered to participate in the trial, he said.Several research organisations from across the country and outside have been eagerly waiting for such a unit in this part of the country to generate evidence in clinical research, based on factors such as local population, Rao said.

       People willing to volunteer for the vaccine trial can contact the institute. All details are displayed on its website,” the professor said.